Delivery Order SPE2DB22D3010-SPE2DB26FP0UJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,190.65. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,216.65 delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a contract ceiling value of $1,801.61. This firm fixed-price delivery order, which is set to conclude on September 30, 2025, represents a non-set-aside competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,288.66 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Methylphenidate ER 27 mg tablets in quantities of 100. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under an open competition process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $2,071.52. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,386.06. This firm fixed-price delivery order, which is expected to be completed by July 30, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count units) on May 12, 2025, with a ceiling value of $1,533.59 and an ultimate completion date of May 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Methylphenidate ER 27 mg tablets in quantities of 100 units. This competitive award, valued at $1,167.86 with a firm fixed price structure, represents a single delivery order without set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a $1,978.18 delivery order by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles). This firm fixed-price, competitively awarded contract is scheduled for completion by September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child delivery order under a larger contract...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB26FP0UJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count packaging) with a ceiling value of $1,312.22. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for ultimate completion by October 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen maintains an extensive portfolio of generic and brand-name medications, vaccines, and medical supplies supporting military healthcare programs globally. The company's track record of competitive awards across diverse therapeutic domains demonstrates its capability to meet federal medical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/29/25 |